{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Apremilast  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Apremilast. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Apremilast  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "apremilast",
    "trial_2_text": "Apremilast  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Apremilast Supplement: 60 participants will take Apremilast 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Apremilast. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Apremilast  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.3121902048587799,
      "78": 0.26628708839416504,
      "9": 0.21420694887638092,
      "173": 0.2117120623588562,
      "17": 0.16908572614192963,
      "37": 0.12526699900627136,
      "77": 0.1238430067896843,
      "21": 0.12374222278594971,
      "46": 0.11859547346830368,
      "177": 0.11707457900047302,
      "64": 0.11374063044786453,
      "123": 0.11199241131544113,
      "68": 0.1114911437034607,
      "20": 0.11010614782571793,
      "79": 0.10034195333719254,
      "139": 0.09812072664499283,
      "104": 0.09697183221578598,
      "49": 0.09545522183179855,
      "189": 0.09501815587282181,
      "85": 0.09166193008422852,
      "151": 0.09068489074707031,
      "86": 0.09020671248435974,
      "131": 0.089632049202919,
      "14": 0.08955313265323639,
      "228": 0.08884377777576447,
      "76": 0.0874127522110939,
      "200": 0.08686216175556183,
      "67": 0.08632437884807587,
      "188": 0.08550842851400375,
      "116": 0.08307385444641113,
      "126": 0.08223121613264084,
      "239": 0.08188536763191223,
      "114": 0.07500345259904861,
      "30": 0.0741100162267685,
      "396": 0.0716911107301712,
      "243": 0.07125324755907059,
      "441": 0.07021965086460114,
      "5": 0.06711886823177338,
      "456": 0.0666758343577385,
      "92": 0.06408284604549408,
      "204": 0.06301409006118774,
      "180": 0.060794614255428314,
      "138": 0.05997540429234505,
      "199": 0.05971456319093704,
      "61": 0.05966276675462723,
      "29": 0.058453477919101715,
      "102": 0.058338358998298645,
      "147": 0.05570616573095322,
      "11": 0.05556093528866768,
      "276": 0.054350536316633224,
      "101": 0.05272943153977394,
      "27": 0.051289863884449005,
      "350": 0.050630178302526474,
      "2": 0.050297822803258896,
      "122": 0.04967952147126198,
      "75": 0.04951358959078789,
      "361": 0.04891345649957657,
      "38": 0.04877782240509987,
      "72": 0.048004139214754105,
      "466": 0.04742247983813286,
      "195": 0.046967893838882446,
      "269": 0.04694970324635506,
      "118": 0.046638697385787964,
      "18": 0.04635164141654968,
      "193": 0.04498149827122688,
      "15": 0.04458250105381012,
      "96": 0.04428054764866829,
      "211": 0.04353152588009834,
      "355": 0.0434211790561676,
      "297": 0.04299009591341019,
      "98": 0.041711777448654175,
      "203": 0.04149870574474335,
      "33": 0.04088837653398514,
      "28": 0.040160395205020905,
      "132": 0.03963209688663483,
      "69": 0.03915496543049812,
      "31": 0.03722119331359863,
      "97": 0.03680180385708809,
      "105": 0.036492977291345596,
      "261": 0.036221589893102646,
      "382": 0.03533969074487686,
      "191": 0.03488423302769661,
      "130": 0.03478122130036354,
      "136": 0.03445662558078766,
      "371": 0.03443636745214462,
      "253": 0.03437111899256706,
      "164": 0.03385508432984352,
      "179": 0.03353654593229294,
      "489": 0.03350527957081795,
      "394": 0.033148761838674545,
      "194": 0.03313256800174713,
      "356": 0.032970961183309555,
      "35": 0.032398924231529236,
      "40": 0.0322192944586277,
      "286": 0.032122500240802765,
      "186": 0.03210366889834404,
      "454": 0.03209777921438217,
      "163": 0.03154381737112999,
      "422": 0.03149105980992317,
      "282": 0.03130817785859108
    },
    "trial_2_ae": {
      "87": 0.3121902048587799,
      "78": 0.26628708839416504,
      "9": 0.21420694887638092,
      "173": 0.2117120623588562,
      "17": 0.16908572614192963,
      "37": 0.12526699900627136,
      "77": 0.1238430067896843,
      "21": 0.12374222278594971,
      "46": 0.11859547346830368,
      "177": 0.11707457900047302,
      "64": 0.11374063044786453,
      "123": 0.11199241131544113,
      "68": 0.1114911437034607,
      "20": 0.11010614782571793,
      "79": 0.10034195333719254,
      "139": 0.09812072664499283,
      "104": 0.09697183221578598,
      "49": 0.09545522183179855,
      "189": 0.09501815587282181,
      "85": 0.09166193008422852,
      "151": 0.09068489074707031,
      "86": 0.09020671248435974,
      "131": 0.089632049202919,
      "14": 0.08955313265323639,
      "228": 0.08884377777576447,
      "76": 0.0874127522110939,
      "200": 0.08686216175556183,
      "67": 0.08632437884807587,
      "188": 0.08550842851400375,
      "116": 0.08307385444641113,
      "126": 0.08223121613264084,
      "239": 0.08188536763191223,
      "114": 0.07500345259904861,
      "30": 0.0741100162267685,
      "396": 0.0716911107301712,
      "243": 0.07125324755907059,
      "441": 0.07021965086460114,
      "5": 0.06711886823177338,
      "456": 0.0666758343577385,
      "92": 0.06408284604549408,
      "204": 0.06301409006118774,
      "180": 0.060794614255428314,
      "138": 0.05997540429234505,
      "199": 0.05971456319093704,
      "61": 0.05966276675462723,
      "29": 0.058453477919101715,
      "102": 0.058338358998298645,
      "147": 0.05570616573095322,
      "11": 0.05556093528866768,
      "276": 0.054350536316633224,
      "101": 0.05272943153977394,
      "27": 0.051289863884449005,
      "350": 0.050630178302526474,
      "2": 0.050297822803258896,
      "122": 0.04967952147126198,
      "75": 0.04951358959078789,
      "361": 0.04891345649957657,
      "38": 0.04877782240509987,
      "72": 0.048004139214754105,
      "466": 0.04742247983813286,
      "195": 0.046967893838882446,
      "269": 0.04694970324635506,
      "118": 0.046638697385787964,
      "18": 0.04635164141654968,
      "193": 0.04498149827122688,
      "15": 0.04458250105381012,
      "96": 0.04428054764866829,
      "211": 0.04353152588009834,
      "355": 0.0434211790561676,
      "297": 0.04299009591341019,
      "98": 0.041711777448654175,
      "203": 0.04149870574474335,
      "33": 0.04088837653398514,
      "28": 0.040160395205020905,
      "132": 0.03963209688663483,
      "69": 0.03915496543049812,
      "31": 0.03722119331359863,
      "97": 0.03680180385708809,
      "105": 0.036492977291345596,
      "261": 0.036221589893102646,
      "382": 0.03533969074487686,
      "191": 0.03488423302769661,
      "130": 0.03478122130036354,
      "136": 0.03445662558078766,
      "371": 0.03443636745214462,
      "253": 0.03437111899256706,
      "164": 0.03385508432984352,
      "179": 0.03353654593229294,
      "489": 0.03350527957081795,
      "394": 0.033148761838674545,
      "194": 0.03313256800174713,
      "356": 0.032970961183309555,
      "35": 0.032398924231529236,
      "40": 0.0322192944586277,
      "286": 0.032122500240802765,
      "186": 0.03210366889834404,
      "454": 0.03209777921438217,
      "163": 0.03154381737112999,
      "422": 0.03149105980992317,
      "282": 0.03130817785859108
    }
  },
  "safety": {
    "trial_1_safety": 0.3317023515701294,
    "trial_2_safety": 0.3317023515701294
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4779774844646454
  }
}